Tasso, a Seattle-based telemedicine company that specializes in remote, self-sampled blood collection, has raised $17 million in a series A round of funding. The telehealth market has boomed over the ...

Tasso has taken a major step forward in its plans to make quick, easy and widespread blood tests a reality, with an FDA clearance for its simple sample collection device. The Tasso+ lancet can be ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, surveyed more than 600 adults (age 18-65+) within the United States to assess ...

Ben Casavant, PhD, CEO & Co-Founder of Tasso Inc. The collaboration positions Neurogen at the forefront of globally building a scalable, home-based model for Alzheimer’s-related biomarker testing and ...

Tasso received FDA 510(k) clearance for its patch-like blood collection device, the Tasso+. The device includes a lancet, which adheres to the arm, that connects to a test tube for collection. After ...

Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, and Tasso, Inc., the leading provider of patient ...

Tasso, Inc. has completed a $6.1 million financing round led by Vertical Venture Partners (“VVP”), with participation from Techstars and Cedars-Sinai. This funding will help Tasso scale its first ...

Tasso, which specializes in clinical-grade blood collection, is partnering with United BioSource to make sample collection and analysis more efficient and easier for patients taking part in clinical ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...

Tasso has partnered with women's healthcare company SheMed to offer at-home blood testing for weight loss treatments in the UK. This collaboration aims to personalise glucagon-like peptide-1 (GLP-1) ...